However, support for the relevance of envelope protein in SARS‐CoV‐2 pathogenesis comes from the findings that envelope protein alone causes lung inflammation in mice when inhaled, that an experimental envelope protein vaccine reduced lung pathology in mice, and that circulating envelope protein levels correlate with COVID‐19 severity in patients [9, 16, 63]. The gene discussed is ERVW-1; the disease is inflammation.